Delivery Order SPE2DB22D3016-SPE2DB24FAJZ1
Award Date 1/22/24
Potential Completion Date 1/23/24
Potential Value $35K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, the prime contractor, for the supply of a pharmaceutical product called MENQUADFI VIAL 0.5ML. The order has a potential value of $5,111.04 and a completion date of March 4, 2024. Amerisourcebergen Drug Corp is a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The company provides a wide range of...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $3,512.40 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide MENQUADFI VIAL 0.5ML pharmaceutical products. The contract has a completion date of January 29, 2024. Amerisourcebergen Drug Corp is the prime contractor and does not have any major subcontractors identified. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The $74,097.05 award is for the supply of 4563225576 ! MENQUADFI VIAL 0.5ML, a pharmaceutical product. The delivery order has a completion date of January 4, 2024 and was awarded on January 3, 2024. No set-aside designation was used. Amerisourcebergen Drug Corp has received...
- The U.S. Defense Logistics Agency (DLA) awarded a $2,435.58 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide MENQUADFI VIAL 0.5ML pharmaceuticals. The order is set to be completed by December 7, 2023 and was awarded on December 6, 2023. Amerisourcebergen Drug Corp, through its Corporate Office division, is a prime contractor that has received numerous federal contract awards from DLA to supply pharmaceuticals, medical...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The contract is for the delivery of MENQUADFI VIAL 0.5ML, with a potential value of $2,107.44 and a completion date of January 29, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a potential value of...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of MENQUADFI VIAL 0.5ML pharmaceuticals. The firm fixed price delivery order has a potential value of $2,809.92 and a completion date of December 22, 2023. Amerisourcebergen Drug Corp, through its Corporate Office division, is a prime contractor that provides a range of pharmaceutical products and medical...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order, valued at $9,039.53, is for MENQUADFI VIAL 0.5ML medical supplies. The contract has a period of performance through January 9, 2025 and is a firm fixed-price delivery order. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary...
- This is a delivery order with a firm fixed price valued at $86,637.35 awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division. The contract is for the supply of pharmaceutical products, specifically MENQUADFI VIAL 0.5ML, to support various government agencies and healthcare programs. Amerisourcebergen is a major pharmaceutical distributor that has been awarded numerous federal contracts, including an Indefinite Delivery Contract (IDC)...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The order, valued at $77,311.05, is for the delivery of MENQUADFI VIAL 0.5ML pharmaceutical products to support military treatment programs and facilities. There is no set-aside designation associated with this contract. Amerisourcebergen Drug Corp serves as a prime contractor...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office division. The award, valued at $4,214.88, is for the supply of MENQUADFI VIAL 0.5ML, a pharmaceutical product. The contract is a Firm Fixed Price delivery order with a completion date of September 13, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous contracts by the DLA and other federal agencies to...